Published online before print November 6, 2008

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2008.080407v1 173/6/1693    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nigrovic, P. A. Articles by Lee, D. M. Search for Related Content PubMed PubMed Citation Articles by Nigrovic, P. A. Articles by Lee, D. M.

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.080407

Accepted for publication September 9, 2008.

Article

Genetic Inversion in Mast Cell-Deficient W^sh Mice Interrupts Corin and Manifests as Hematopoietic and Cardiac Aberrancy

Peter A. Nigrovic^*, Daniel H.D. Gray, Tatiana Jones^*, Jenny Hallgren^*, Frank C. Kuo, Blair Chaletzky^*, Michael Gurish^*, Diane Mathis^*, Christophe Benoist^*, and David M. Lee^*@

From the Division of Rheumatology, Immunology and Allergy,* Brigham and Women's Hospital, Boston; Division of Immunology, Children's Hospital Boston, Boston; Section on Immunology and the Immunogenetics, Joslin Diabetes Center, Boston; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

^@ To whom correspondence should be addressed. E-mail: dlee{at}rics.bwh.harvard.edu.

	Abstract

Mast cells participate in pathophysiological processes that range from antimicrobial defense to anaphylaxis and inflammatory arthritis. Much of the groundwork for the understanding of mast cells was established in mice that lacked mast cells through defects in either stem cell factor or its receptor, Kit. Among available strains, C57BL/6-Kit^W-sh (W^sh) mice are experimentally advantageous because of their background strain and fertility. However, the genetic inversion responsible for the W^sh phenotype remains poorly defined, and its effects beyond the mast cell have been incompletely characterized. We report that W^sh animals exhibit splenomegaly with expanded myeloid and megakaryocyte populations. Hematopoietic abnormalities extend to the bone marrow and are reflected by neutrophilia and thrombocytosis. In contrast, mast cell-deficient WBB6F1-Kit^W/Kit^W-v (W/W^v) mice display mild neutropenia, but no changes in circulating platelet numbers. To help define the basis for the W^sh phenotype, a "DNA walking" strategy was used to identify the precise location of the 3' breakpoint, which was found to reside 67.5 kb upstream of Kit. The 5' breakpoint disrupts corin, a cardiac protease responsible for the activation of atrial natriuretic peptide. Consistent with this result, transcription of full-length corin is ablated and W^sh mice develop symptoms of cardiomegaly. Studies performed using mast cell-deficient strains must consider the capacity of associated abnormalities to either expose or compensate for the missing mast cell lineage.

This article has been cited by other articles:

				L. Biggs, C. Yu, B. Fedoric, A. F. Lopez, S. J. Galli, and M. A. Grimbaldeston Evidence that vitamin D3 promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice J. Exp. Med., March 15, 2010; 207(3): 455 - 463. [Abstract] [Full Text] [PDF]

				N. Dong, S. Chen, J. Yang, L. He, P. Liu, D. Zheng, L. Li, Y. Zhou, C. Ruan, E. Plow, et al. Plasma Soluble Corin in Patients With Heart Failure Circ Heart Fail, March 1, 2010; 3(2): 207 - 211. [Abstract] [Full Text] [PDF]

				A. M. Piliponsky, C.-C. Chen, M. A. Grimbaldeston, S. M. Burns-Guydish, J. Hardy, J. Kalesnikoff, C. H. Contag, M. Tsai, and S. J. Galli Mast Cell-Derived TNF Can Exacerbate Mortality during Severe Bacterial Infections in C57BL/6-KitW-sh/W-sh Mice Am. J. Pathol., February 1, 2010; 176(2): 926 - 938. [Abstract] [Full Text] [PDF]

				M.-R. Blanchet, M. Gold, S. Maltby, J. Bennett, B. Petri, P. Kubes, D. M. Lee, and K. M. McNagny Loss of CD34 Leads To Exacerbated Autoimmune Arthritis through Increased Vascular Permeability J. Immunol., February 1, 2010; 184(3): 1292 - 1299. [Abstract] [Full Text] [PDF]

				T. Kawakami A Crucial Door to the Mast Cell Mystery Knocked In J. Immunol., December 1, 2009; 183(11): 6861 - 6862. [Full Text] [PDF]

				T. N. Mayadas, G. C. Tsokos, and N. Tsuboi Mechanisms of Immune Complex-Mediated Neutrophil Recruitment and Tissue Injury Circulation, November 17, 2009; 120(20): 2012 - 2024. [Full Text] [PDF]

				S. Piconese, G. Gri, C. Tripodo, S. Musio, A. Gorzanelli, B. Frossi, R. Pedotti, C. E. Pucillo, and M. P. Colombo Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation Blood, September 24, 2009; 114(13): 2639 - 2648. [Abstract] [Full Text] [PDF]

				D. J. Haddon, F. Antignano, M. R. Hughes, M.-R. Blanchet, L. Zbytnuik, G. Krystal, and K. M. McNagny SHIP1 Is a Repressor of Mast Cell Hyperplasia, Cytokine Production, and Allergic Inflammation In Vivo J. Immunol., July 1, 2009; 183(1): 228 - 236. [Abstract] [Full Text] [PDF]

				Y. Zhou, J. Jiang, Y. Cui, and Q. Wu Corin, atrial natriuretic peptide and hypertension Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1071 - 1073. [Full Text] [PDF]